Background illustration for clinical trials search

Sarcoma Clinical Trials

Browse 918 sarcoma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma

for
Mesothelioma, Mesothelioma; Lung, Mesotheliomas Pleural,
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07126509

Recruiting

A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma

for
Primary Vitreoretinal Lymphoma
Location: Miami FL
Sponsor: Aldeyra Therapeutics, Inc.

Sex: All

Age: 21+

Code: NCT07402876

Phase3, Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Norfolk VA, Silver Spring MD, Fairfax VA, Durham NC,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase2, Recruiting

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

for
Burkitt Lymphoma, Double-Expressor Lymphoma,
Location: Pittsburgh PA, Kansas City KS, Westwood KS, Fairway KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07069699

Phase1, Phase2, Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07104032

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

for
Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL)
Location: York PA, Bethesda MD, Charlotte NC, Columbus OH,
Sponsor: Tempus AI

Sex: All

Age: 0+

Code: NCT07154823

Recruiting

An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers

for
Lymphoma, Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 70+

Code: NCT07226934

Recruiting

Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

for
CLL/SLL, CLL, SLL, Chronic Lymphocytic Leukemia,
Location: Cincinnati OH
Sponsor: Zulfa Omer

Sex: All

Age: 18+

Code: NCT07108998

Phase2, Recruiting

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

for
B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07097363

Phase2, Recruiting

Mosunetuzumab for CLL MRD Clearance

for
Leukemia, Chronic Lymphocytic Leukemia,
Location: Boston MA
Sponsor: Inhye Ahn

Sex: All

Age: 18+

Code: NCT07052695

Phase1, Phase2, Recruiting

Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma,
Location: Cincinnati OH
Sponsor: Zulfa Omer

Sex: All

Age: 18+

Code: NCT07014917

Phase2, Recruiting

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

for
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
Location: Baltimore MD, Charlottesville VA, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07003295

Phase2, Recruiting

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

for
B-cell Non-Hodgkin Lymphoma
Location: New York NY, Jacksonville FL, Franklin TN, Rochester MN
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07123454

Phase1, Phase2, Recruiting

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Scarborough ME, Boston MA
Sponsor: Inhye Ahn

Sex: All

Age: 18+

Code: NCT06333262

Phase2, Recruiting

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

for
T-cell Lymphoma, Graft Versus Host Disease, Lymphoma, T-Cell,
Location: Columbus OH
Sponsor: Jonathan Brammer

Sex: All

Age: 18+

Code: NCT07356245

Phase2, Recruiting

Survivors Uniting for Remote Guided Exercise

for
Cancer,
Location: Fort Collins CO
Sponsor: Colorado State University

Sex: All

Age: 18+

Code: NCT07290309

Recruiting

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Newnan GA, Irvine CA, Duarte CA, Long Beach CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07218510

Phase2, Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Hackensack NJ, Norfolk VA, Durham NC, Buffalo NY,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase3, Recruiting

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

for
Recurrent Chronic Lymphocytic Leukemia,
Location: Boston MA, Chapel Hill NC, Pittsburgh PA, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061951

Phase2, Recruiting

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

for
Multiple Myeloma, Hodgkin Lymphoma, Non-hodgkin Lymphoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT07188090

Phase2, Recruiting